Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?

Transplant infectious disease : an official journal of the Transplantation Society(2023)

引用 0|浏览25
暂无评分
摘要
No clear relationship between ganciclovir C and neither CMV eradication nor safety issues was identified.
更多
查看译文
关键词
ganciclovir, leukopenia, preemptive therapy, solid organ transplant recipients, therapeutic drug monitoring, valganciclovir
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要